🇺🇸 FDA
Patent

US 12077572

Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof

granted A61KA61K2039/505A61K47/68

Quick answer

US patent 12077572 (Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K47/68